The atrophic variant of dermatofibrosarcoma protuberans in childhood: a report of six cases.

Ludovic Martin(Dassault Aviation (France)), P Grimand, M Dupin, B Chouvet, P. Combemale(Centre Léon Bérard), G Dubreuil, M.-L. Bouyssou-Gauthier, A Claudy, Jean Kanitakis(Hôpital Lyon Sud)

PubMed

October 1, 1998

Cited by 81

Related Papers

Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial

|The Lancet Oncology|2015|432

Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study

|British Journal of Dermatology|2019|197

Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement

|Cytogenetics and Cell Genetics|2008|194

Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study

|Journal of the European Academy of Dermatology and Venereology|2017|192

Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966

|Orphanet Journal of Rare Diseases|2020|188